Wissenschaftliche Leitung
Prof. Dr. med. Tobias Keck
Direktor
Klinik für Chirurgie
UKSH Campus Lübeck
Prof. Dr. Tobias Keck started his medical career at the Department of Surgery at the University of Heidelberg. After two years of research at the Massachusetts General Hospital, Harvard Medical School, in the Pancreas Research lab, he returned to the Department of Surgery at the University of Freiburg and became Vice Chair of the Department in 2009. He was elected Chairmen of the Department of Surgery at the University of Lübeck in 2012, which includes visceral surgery, general surgery, thoracic surgery and vascular surgery as well as transplantation surgery. The main focus of the clinical work of Professor Keck is minimal-invasive oncologic surgery.
Professor Keck is Chair of the Working chapter of Robotics and Innovation in Surgery of the Association of General and Visceral Surgeons in Germany. He is a member of the Collegiate of the German Research Foundation (DFG) and member of numerous societies Since several years he is General Secretary of the German Chapter of the ACS. Additionally, Professor Keck is member of editorial boards of numerous scientific journals. He is Honorary Professor of two Ukrainian Universities, Bogomolets National Medical University, Kiew and Vinnytsia National Pirogov Memorial Medical University.
The Department of Surgery at the University of Lübeck is German Center of Excellence for minimal-invasive surgery (DGAV).The main focus of research of the Department lies within hepato-pancreato-biliary oncology, oncologic research and minimal-invasive surgery in the clinical context.
Prof. Dr. med. Jens U. Marquardt
Direktor
Medizinische Klinik I
UKSH Campus Lübeck
Prof. Dr. Marquardt received his MD degree from the University of Heidelberg, Germany (Division of Toxicology and Cancer Risk Factors, German Cancer Research Center, Heidelberg, Germany). From 2008-2011 he performed a postdoctoral-fellowship at the Laboratory of Experimental Carcinogenesis (CCR/NCI/NIH), Bethesda under the mentorship of Dr. Snorri S. Thorgeirsson where his research focused on the functional and molecular characterization of hepatic cancer stem cells. From 2011 - 2019 he worked as an attending physician in the GI and hepatobiliary oncology section of the Department of Medicine I, University of Mainz, Germany. In 2015 Dr. Marquardt was awarded with a Lichtenberg-Professorship for molecular hepatocarcinogenesis by the Volkswagen Foundation. In November 2019 he was appointed as full professor for Gastroenterology at the University of Lübeck and head of the Department of Medicine I, University Medical Center Schleswig-Holstein – Campus Lübeck. Dr. Marquardt serves on the editorial board of several peer-reviewed journals including Carcinogenesis, Cancers and BMC Genomics. His clinical focus is hepatobiliary malignancies. Current research activities involve several aspects of translational hepatocarcinogenesis, hepatic cancer stem cells and systems hepatology.
Prof. Dr. med. Nikolas von Bubnoff
Direktor
Klinik für Hämatologie und Onkologie
UKSH Campus Lübeck
Prof. Dr. Nikolas von Bubnoff ist Direktor der Klinik für Hämatologie und Onkologie am Campus Lübeck. Er hat am 15. Januar 2019 die Leitung der neu gegründeten Klinik übernommen. Vor seinem Wechsel an das UKSH war Prof. von Bubnoff seit 2012 Oberarzt und Stellvertretender Direktor des Comprehensive Cancer Center Freiburg (CCCF) am Universitätsklinikum Freiburg/Breisgau. Seine medizinische Ausbildung absolvierte er an der Ludwig-Maximilians-Universität München, wo er 1999 mit dem Prädikat magna cum laude promovierte. Von 1997 bis 2012 war Prof. von Bubnoff am Klinikum rechts der Isar der Technischen Universität München tätig, zuletzt als Oberarzt. 2005 erhielt er seine Facharztanerkennung sowie 2006 seine venia legendi im Fachgebiet Innere Medizin.
Die Forschungsschwerpunkte von Prof. von Bubnoff umfassen onkogene Signalwege bei Therapieresistenz, zirkulierende Tumor-DNA als Biomarker, experimentelle GvHD-Therapie sowie Homing bei Hirnlymphomen. In seiner neuen Position als Direktor der Klinik für Hämatologie und Onkologie möchte Prof. von Bubnoff zu einer Optimierung der interdisziplinären Strukturen am Onkologischen Zentrum, Campus Lübeck, beitragen und die Weiterentwicklung der onkologischen Versorgung am UKSH campusübergreifend zu einem onkologischen Spitzenzentrum (CCC) vorantreiben. Dabei möchte er auch die Netzwerkbildung mit regionalen Praxen und Krankenhäusern sowie die Zusammenarbeit mit den Patienten stärken. Um individualisierte Therapiestrategien voranzutreiben, möchte Prof. von Bubnoff einen interdisziplinären Schwerpunkt für molekulare Onkologie am Standort implementieren.